Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
salazopyrin en-tabs magasýruþolin tafla 500 mg
pfizer aps - sulfasalazinum inn - magasýruþolin tafla - 500 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
sobril tafla 10 mg
pfizer aps - oxazepamum inn - tafla - 10 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
sobril tafla 15 mg
pfizer aps - oxazepamum inn - tafla - 15 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
sobril tafla 25 mg
pfizer aps - oxazepamum inn - tafla - 25 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
solu-medrol stungulyfsstofn og leysir, lausn 40 mg
pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 40 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
synarela nefúði, lausn 2 mg/ml
pfizer aps - nafarelinum acetat - nefúði, lausn - 2 mg/ml
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax filmuhúðuð tafla 500 mg
pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax mixtúruduft, dreifa 40 mg/ml
pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
Исландия -
исландски -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax stofn fyrir innrennslisþykkni, lausn 500 mg
pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg
Европейски съюз -
исландски -
EMA (European Medicines Agency)
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - Ónæmisbælandi lyf - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.